𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia

✍ Scribed by William Insull Jr.; Michael Koren; Jean Davignon; Dennis Sprecher; Helmut Schrott; Leonard M Keilson; Alan S Brown; Carlos A Dujovne; Michael H Davidson; Richard McLain; Therese Heinonen


Book ID
119434050
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
119 KB
Volume
157
Category
Article
ISSN
0021-9150

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Short- and long-term effects of lovastat
✍ B. G. Jacob; W. MΓΆhrle; W. O. Richter; P. Schwandt πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 612 KB

The effects of the HMG CoA reductase inhibitors lovastatin and pravastatin on serum lipids, lipoproteins and apolipoproteins have been studied in 35 patients with primary hypercholesterolaemia. LDL cholesterol was lowered to the same extent by both agents compared on a mg basis of each drug per day.